02496.HK 株価推移チャート
YZYBIO-B (02496.HK)
Wuhan YZY Biopharma Co., Ltd.
HK$0
0%
$0
休場: May 07, 16:00:00 HKT
戻る
Wuhan YZY Biopharma Co., Ltd. (02496.HK)
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
配当利回り
--
1株当たり利益(TTM)
--
時価総額
--
YZYBIO-Bとは何ですか？
Wuhan YZY Biopharma Co., Ltd. engages in the research, development, and industrialization of bispecific drugs. The company is headquartered in Wuhan, Hubei and currently employs 106 full-time employees. The company went IPO on 2023-09-25. The firm is committed to developing bispecific antibody (BsAb) based therapies for the treatment of cancer-related complications, cancer, and age-related eye diseases to address the medical needs in oncology and geriatric eye diseases. The firm's core product M701 is a recombinant BsAb that targets human cancer cell surface antigen EpCAM and human T cell surface antigen CD3. The firm's product pipeline also includes Y101D, Y332, Y225, and others.
